Armoring anti-cancer T cells against immunosuppressants
Medical Xpress· 4 days agoDuke-NUS Medical School researchers, together with collaborators in Singapore, have designed armored...
Ask Amy: Brother writes unsettling funeral home dispatches
Denver Post· 15 hours agoDear Amy: I have an older brother who is currently fighting lymphoma and stage 4 liver cancer. It is...
‘My cancer surgery has been delayed, and I’m terrified it may come too late’
The Telegraph via Yahoo News· 12 hours agoMy cancer diagnosis last October came as a shock. Although chemotherapy will keep me alive, it also...
Milk Thistle Promotes Liver Function
Mercola· 5 days agoThroughout history, people have used the fruit and seeds of the milk thistle plant as a treatment for liver disorders. According to the NIH, the oldest...
Cancer Surgery Mortality Down, but Racial Disparities Persist
Medscape· 4 days agoOverall mortality rates after cancer surgery have improved in recent years, but the mortality gap...
Study Explores Changes in Liver Cancer Cell Metabolism in Response to Galactose Sugar
Newswise· 1 day agoArticle title: Global changes to HepG2 cell metabolism in response to galactose treatment Authors:...
Breast Cancer Recurrence
WebMD· 7 days agoWhen breast cancer comes back after treatment and a period of time when it was thought to be gone, it's called recurrence. Only a few cancer cells need...
Philadelphia community mourning loss of restaurant pioneer KeVen Parker
WPVI 6abc Philadelphia· 5 days agoTootsies on Sunday night. Dozens of friends one family gathered to remember restaurant owner KeVen...
Agios Presents Final Data From Phase 3 ClarIDHy Study Of TIBSOVO® (ivosidenib Tablets) In Patients...
TheStreet.com· 5 days agoCAMBRIDGE, Mass., Jan. 17, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. AGIO, a leader in the field of cellular metabolism to treat cancer and
Why Is Fish Good For You? It's Not Because of Omega-3s
Discover· 9 hours agoIn the 1970s, a team of Danish researchers published a study claiming that the Innuit population...